Featured Interview: CEO Jeffrey Bacha of DelMar Pharmaceuticals (NASDAQ: DMPI)

DelMar Pharmaceuticals CEO, Jeffrey Bacha discusses new financing & biologic drug research. Speaking in detail about VAL-083. (NASDAQ: DMPI)




The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.

Leave a Reply